Advertisement
Research ArticleCardiovascular

Differential Effects of Complement Activation Products C3a and C5a on Cardiovascular Function in Hypertensive Pregnant Rats

Kathryn E. Lillegard, Alex C. Loeks-Johnson, Jonathan W. Opacich, Jenna M. Peterson, Ashley J. Bauer, Barbara J. Elmquist, Ronald R. Regal, Jeffrey S. Gilbert and Jean F. Regal
Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 344-351; DOI: https://doi.org/10.1124/jpet.114.218123
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCardiovascular

C3a, C5a, and Pregnancy-Induced Hypertension

Kathryn E. Lillegard, Alex C. Loeks-Johnson, Jonathan W. Opacich, Jenna M. Peterson, Ashley J. Bauer, Barbara J. Elmquist, Ronald R. Regal, Jeffrey S. Gilbert and Jean F. Regal
Journal of Pharmacology and Experimental Therapeutics November 1, 2014, 351 (2) 344-351; DOI: https://doi.org/10.1124/jpet.114.218123
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement